dc.contributor.author |
Datta, Sumona |
|
dc.contributor.author |
Sherman, Jonathan M. |
|
dc.contributor.author |
Bravard, Marjory A. |
|
dc.contributor.author |
Valencia, Teresa |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Evans, Carlton Anthony William |
|
dc.date.accessioned |
2019-02-06T14:52:17Z |
|
dc.date.available |
2019-02-06T14:52:17Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/5292 |
|
dc.description.abstract |
BACKGROUND: It is difficult to determine whether early tuberculosis treatment is effective in reducing the infectiousness of patients' sputum, because culture takes weeks and conventional acid-fast sputum microscopy and molecular tests cannot differentiate live from dead tuberculosis. METHODS: To assess treatment response, sputum samples (n=124) from unselected patients (n=35) with sputum microscopy-positive tuberculosis were tested pretreatment and after 3, 6, and 9 days of empiric first-line therapy. Tuberculosis quantitative viability microscopy with fluorescein diacetate, quantitative culture, and acid-fast auramine microscopy were all performed in triplicate. RESULTS: Tuberculosis quantitative viability microscopy predicted quantitative culture results such that 76% of results agreed within +/-1 logarithm (rS=0.85; P<.0001). In 31 patients with non-multidrug-resistant (MDR) tuberculosis, viability and quantitative culture results approximately halved (both 0.27 log reduction, P<.001) daily. For patients with non-MDR tuberculosis and available data, by treatment day 9 there was a >10-fold reduction in viability in 100% (24/24) of cases and quantitative culture in 95% (19/20) of cases. Four other patients subsequently found to have MDR tuberculosis had no significant changes in viability (P=.4) or quantitative culture (P=.6) results during early treatment. The change in viability and quantitative culture results during early treatment differed significantly between patients with non-MDR tuberculosis and those with MDR tuberculosis (both P<.001). Acid-fast microscopy results changed little during early treatment, and this change was similar for non-MDR tuberculosis vs MDR tuberculosis (P=.6). CONCLUSIONS: Tuberculosis quantitative viability microscopy is a simple test that within 1 hour predicted quantitative culture results that became available weeks later, rapidly indicating whether patients were responding to tuberculosis therapy. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Oxford University Press |
|
dc.relation.ispartofseries |
Clinical Infectious Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Adult |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Young Adult |
en_US |
dc.subject |
Time Factors |
en_US |
dc.subject |
fluorescein diacetate |
en_US |
dc.subject |
early bactericidal activity |
en_US |
dc.subject |
multidrug-resistant tuberculosis |
en_US |
dc.subject |
Sputum/microbiology |
en_US |
dc.subject |
Antitubercular Agents/therapeutic use |
en_US |
dc.subject |
Bacteriological Techniques/methods |
en_US |
dc.subject |
Microscopy/methods |
en_US |
dc.subject |
Drug Monitoring/methods |
en_US |
dc.subject |
Microbial Viability/drug effects |
en_US |
dc.subject |
Tuberculosis/drug therapy |
en_US |
dc.subject |
viability stain |
en_US |
dc.subject |
vital stain tuberculosis |
en_US |
dc.title |
Clinical evaluation of tuberculosis viability microscopy for assessing treatment response |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1093/cid/ciu1153 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.08 |
|
dc.relation.issn |
1537-6591 |
|